2. NAME- Mr X
AGE- 55 YEARS
SEX- MALE
ADDRESS- MANGALORE
OCCUPATION- FACTORY WORKER
PRESENTING COMPLAINTS
HEMATURIA
LOIN PAIN
MASS IN LOIN
INSPECTION LOIN MASS
PALPATION MOBILE,NODULAR,
HARD,MOVES WITH
RESPIRATION
PERCUSSION DULL RENAL ANGLE
3.
4.
5.
6.
7.
8.
9. PATHOLOGY
GROSS– UNILATERAL, UPPER POLE,
LARGE ,GOLDEN YELLOW ,CIRCUMSCRIBED
CUT SECTION - AREA OF NECROSIS,CYSTIC CHANGE,
FOCI OF HAEMORRHAGE,THROMBUS
11. TYPE INCIDENCE GENETICS HISTOLOGY
GRANULAR CELL
TYPE
8% SPORADIC
&
FAMILIAL
ABUNDANT
ACIDOPHILIC
CYTOPLASM
MARKED ATYPIA
CROMOPHOBE TYPE 5% MULTIPLE
CROMOSOMES
LOSS,
HYPODIPLOIDY
•MIXTURE PALE
CLEAR CELL WITH
PERINUCLEAR HALO
•GRANULAR CELL
SARCOMATOID TYPE 1.5%
-------
WHORLS OF
ATYPICAL
ANAPLASTIC
SPINDLE CELLS
COLLECTING DUCT
TYPE
0.5 TUBULAR &
PAPILLARY PATTERN
12. LYMPHATIC
SPREAD
PROLIFERATIVE TROMBUS
EXTENDS INTO IVC
CANNON BALL SECONDARIES
IN LUNG
VARICOCELE DUE TO
BLOCKED LEFT RENAL VEIN
BRAIN,BONE
HILAR & PARA AORTIC
LYMPHNODE
PERINEPHRIC PAD OF FAT,CALYCES
RENAL PELVIS
16. Investigations
1. Urine :- RBCs
2. IVU:- Shows mass lesion and irregular filling defect
3. U/S abdomen:- size, extension, lymph node, status of renal vein, spread to liver.
4. Ct scan:- Confirmatory
status of renal vein and ivc
lymph node status and tumour extension
5. CECT: Early lesions, function, spread and venous status.
6. Renal angiogram:- to access the vascularity.
Seldinger’s technique via transfemoral.
Pharmaco angiogram- tumour blush
Also therapeutic embolisation.
7. MRI/MR ANGIOGRAM:- Tumour thrombus in IVC
8. Chest x-ray:- cannon ball mets
9. Ct chest:-
10. Bone scan.
11. Peripheral smear, serum calcium, haematocrit and ESR
17.
18. A, Magnetic resonance scan
of kidneys without
administration of
gadolinium suggests
anterior right renal mass.
B, After intravenous
administration of
gadolinium-labeled
diethylene-triamine-penta-
acetic acid, MRI shows
enhancement of this mass
indicative of malignancy.
19.
20. Tissue Diagnosis
• Tissue diagnosis obtained from nephrectomy or
biopsy
Papillary (chromophilic) renal cell
carcinoma extending into the
collecting system with histological
findings
21. AJCC (AMERICAN JOINT COMMITTEE
ON CANCER STAGING): TNM STAGING
• TX:- PRIMARY TUMOUR CAN NOT BE ASSESSED
• T0:- NO PRIMARY TUMOUR.
• T1: <7CM limited to kidney
T1a: 0-4CM, T1b: 4-7cm
• T2: >7CM, limited to kidney.
• T3: T3a:- extends to adrenals, perinephric fat
(not gerota’s fascia).
T3b: entends into renal vein or IVC below
diaphragm.
T3c: extends into IVC above diaphragm.
• T4: invades Gerota’s fascia and extends beyond.
22. • N0:- no lymph nodes
• N1:- spread to single region of lymph nodes.
• N2:- spread to more than a group of lymph
nodes.
• M0:- no blood spread.
• M1:- distant spread, lungs 75%, soft tissue,
bones, liver, cns and skin
28. 2. Large fixed tumours:- palliative nephrectomy or debulking is
adviced, why?
3. Bilateral RCC: Bilateral partial nephrectomy is
done.
Renal artery is temporarily ocluded using
vascular clamps and kidney cooled, why?
Resected specimen send for frozen section
biopsy.
retained partial capsule is sutured after heamostasis
arterial clamp released.
32. • Chemotherapy: Vinblastine and progesterone
• Interferons and interleukins.
• Antiangiogenic drugs like endostatin and
angiostatin under trial.
• Humanised monoclonal antibodies like
bevacizumab under trial.
• Laporoscopic approach becoming popular.
Difference?
33. Prognosis
Factors:- 1. tumour size >4cm
2. entension into renal vein
3. presence of secondaries
4. local extension
5. hypercalcaemia and stauffer’s
syndrome.
5 years survival: stage 1 and 2 is 65%
stage 3 is 40%
stage 4 is 10%